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The cfr,crs of mterleukm-4(11-L) on the growth and dlffeeentlatlon of mouse myeloid leukcmla M 1 cells induced by various chfferentlahon mduccrs 
were investlgdted IL-4 alone did not have any srgnlficant effect on the growth or dlffereatlatlon of MI cells, but InhIbIted thclr dlffcrentlatlon 
Induced by dexamethasone, D-factor/leukemia mhtbltory factor, or mterleukm 6 IL-4 also restored the prohfceatlon of Ml cells after growth 
mhtbltion durmg thclr mductlon of dlfferentlatlon by Inducers In contrast, IL-4 enhanced mhtbltlon of growth and mductlon of dlfferentlatlon 
of Ml cells by la,25-dlhydroxyvltamm Dj These results mdlcate that modulation of dlfferentlatIon of Ml cells by IL-4 depends on the 
dlfferentlatton Inducer 
Inteeleukm-4, Dlfferentlatlon, Geowth, Myelmd leukemia cell, Ml cell 
1. INTRODUCTION 
Interleukm-4 (L-4) was first designated as a B cell 
stimulatmg factor-1 from its stimulatory actlvlty on B 
cells [l]. Subsequently, many effects of IL-4 on various 
hematologlcal cell types have been reported [2-61. IL-4 
enhances granulocyte colony formation by hematopole- 
tic progemtors m the presence of granulocyte colony- 
stlmulatmg factor (G-CSF), but Inhibits macrophage 
colony formatlon supported by mterleukm-3 (IL-3) and 
macrophage colony-stlmulatmg factor (M-CSF) [6,7] 
Peck and Bollag [8] reported that IL-4 slightly enhanced 
retmold-induced dlfferentlatlon of human promyelocy- 
tic leukemia I-IL-60 cells, but the effects of IL-4 on the 
growths and differentiations of other myelold leukemia 
cells have scarcely been mvestlgated 
Mouse myelold lcukemla Ml cells [9] can be induced 
to differentrate mto macrophage-hke cells by various 
substances including dexamethasone (Dex) [IO], D-fac- 
tor/Leukemla lnhlbitory factor (D-factor/LIF) [11], m- 
terleukin-6 (IL-6) [12] and la,25dlhydroxyvltamm D3 
(VD3) [I 31. In this study, we exammed whether IL-4 
modulates growth and dlfferentlatlon of Ml cells. 
2. MATERIALS AND METHODS 
2 1 C/lowto/r 
Rccombrnant mouse IL-4 wrls purchdscd from Genzyme (Cam- 
bndgc, MA) Dcx wds obtdmcd from Sigma Chermcal Co Rccombl- 
Currcl/turtftcrtLccrrklrc,r T Kd5ukabc, Dcpdrtmcrrt of Chcmothcrqy. 
S,utatnd Cancer Ccntcr Rcscdrch Instltutc, Inr-macho, SeUrnd 362, 
Japan Pax (81) (48) 722 1739 
nant human D-factor/LIF was purified to homogeneity from condo- 
honed medmm of CHO cells teansfected with a plasmld contammg 
cDNA encoding the D-factor/LIF [I43 Human recombmant IL-6 and 
VD3 were obtdmcd from AJmomoto (Kawasaki, Japan) and Chugal 
Phaemdceutlcat Co (Tokyo, Japan), respectively 
2 2 Cell Ime and cell culture 
Mouse myelold leukemia MI (clone S-2 and clone Y22-3) cells 
[15,16] wele cultured m suspension m Eagle’s mnumum cssentlal me- 
dlum with twrce the normal concentratlons of ammo acrds and vita- 
mms, and supplemented with 10% heat-mactlvated calf strum 
2 3 Assay of properrres of dflferentrared cell 
Phagocytlc dctlvlty wds assayed as reported previously [17] The 
percentage of cells thdt were morphologically slmllar to macrophages 
wds detcrmmed m May-Gruenwald- Gtemsd-stamed smedrs 
3 RESULTS 
3.1 I Effects of IL-4 on growth unci djjferentlatron of MI 
cell.3 
We first exammed the effect of recombinant mouse 
IL-4 on growth of Ml cells. After 4 days culture of Ml 
cells seeded at 4~10~ cells/ml with and without various 
concentrations (3-300 U/ml) of IL-4, cell numbers were 
essentially similar (data not shown). Moreover, IL-4 did 
not induce any morphologlcal change (Table I), phago- 
cytlc actlvlty (Fig. 1) or lysozymc activity (data not 
shown) of Ml cells 
Next, we cxammed whether IL-4 modulated the m- 
ductlon of dtfferentlation of Ml cells by V~IIOUS indu- 
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IL-B (U/ml) 
Fig 1 Effect of IL-4 on the mductlon of phngocytlc actlvtty of Ml 
cells by Deu MI clone S-2 cells (2x10’ cells/ml) were cultured with 
dlffcrent concentrations of IL-4 m the presence (0) or absence (0) of 
?xIO-~ M Dex for 2 days Bars, SD (n=3) 
cers M 1 cells were cultured with Dex, a potent chemical 
inducer ofdlfferentmtlon for Ml cells, m the presence 
or absence of IL-4 for 4 days (Table I). lL-4 clearly 
inhIbIted Dex-mduced morphologlcal dlfferentlatlon. 
This dlfferentlatlon was nccompanied by a decrease m 
cell growth Interestmgly, this growth mhlbitlon m- 
duced by Dex was also InhibIted by IL-4 (Table I). IL-4 
also caused dose-dependent rnhlbltlon of Dex-Induced 
phagocytlc activity, a typical functlonal marker of dlffe- 
rentlatlon, of Ml cells (Rg 1) When Ml cells were 
cultured with 2x10-’ M Dex for 2 days, the concentra- 
tlon of IL-4 for 50% inhlbitlon of phagocytlc actlvlty 
was 3 U/ml IL-4 (15 U/ml) exerted more than 60% 
mhlbltion of Dex-induced phagocytlc actlvlty of Ml 
cells throughout the mcubatlon period (day 1 to day 3) 
(data not shown) IL-4 also inhibited lysozyme actlvlty, 
a typIcal blochemlcal marker of dlfferentlatlon of Ml 
cells, induced by Dex (data not shown) 
We next exammed whether IL-4 Inhibited the dlffe- 
rentlation of M 1 cells induced by other dlfferentiatron 
inducers Ml cells were cultured with 0 2 ng/ml D-fac- 
tor/LIF, a proternous inducer of Ml cells, m the pres- 
ence or absence of various concentrations of IL-4 for 4 
days As shown m Fig 2, IL-4 also caused dose-depen- 
dent mhlbltlon of D-factor/LIF-Induced morpholog&d 
Tdblc I 
Effect of IL-4 on mduLt!on of dtllcrcnrl~~tlon of MI cells by Dcx 
Cell type (%) 
-- 
No 01 cells Cells In 
Traltnicnl (xIO~ccll~n~l) Bl,lSPl In~c~mcd~u~c M.Icroph,lgc\ 
NOIIC 131 “H 99O~IO IO?:lO 0 
IL-4 I35 ICG 087ro6 11klO 0 
DC% 39 15 56OJ42 26 0 i? t 180~20 
Bet + IL-4 H5 .kH ‘)OO.!Z36 x7i.70 13kO6 
-_ 
MI clone S-2 celk (3x10* ~clklnrl) were ~ulk~lcd with 2x10 ’ M DC\ 
111 the prcscncc or dbtencc of 7 S Ulml IL-J for 4 d,ry\ V.~lucr drc 
IllCdllS * SD (w=3 
October 1991 
IL-4 (!Jlml) 
Fig 2 Effect of IL-4 on the mductlon of morphologIcal dlfferentlatlon 
of MI cells by D-faLtor/LIF MI clone T22-3 cells (3~10~ cells/ml) 
were cultured with dlfterent concentrations of IL-4 In the presence (@) 
or dbsence (0) of 0 2 ndml D-factor/LIF for 4 days Then morpho- 
logml change (A) and the number of cells (i3) were dssdyed The 
number of cells m control cultures with or without D-factor/L IF were 
2 4x10’ cells/ml dnd 8 4x10’ cells/ml, respcchvely Bars. SD (n=3) 
dlffercntlatron of h/B I cells The decrease in cell growth 
caused by D-factor/LIF was also Inhibited dosc-depcn- 
dently by IL-4 IL-4 mhlblted the D-factor/LIF-induced 
phagocytlc actlvlty of M 1 cells (data not shown). More- 
over, It also mhlblted the phagocytlc actlvlty Induced by 
IL-6, another protemous Inducer, (FIN 3) and by EG-6, 
an ethylcneglycol-type non-phosphorus alkyl ethel hpld 
[18] (data not shown) The mhlbitlons of growth of Ml 
cells by IL-6 and EGG as well as by Dex and D-factor/ 
LIF were counteracted by IL-4 (ddtd not shown) 
IL-L (U/ml) 
kg 1 Efkrt of IL-4 on the mductlon of phdgocyttc .irtlvity of MI 
cell% by ILG Ml cloncT22-3 ccllr (2xlO’ccils/ml) wcrc cukurcd wtth 
Jllkrcnt conccntr.Hion\ of IL-4 III the pmcncc (0) or dbseficc ( ,) of 
50 U/ml IL-6 for 2 ddys Udrs. SD (rr=3) 
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3 3 &@c I of I&4 on VDS-mduced gjcrenzcatlon of MI 
c ek 
Durmg exatntnatton of the effect of IL-4 on the m- 
ductlon of dlfferentlatlon of M 1 cells by different types 
of mducels, we found that IL-4 enhanced VD3-Induced 
dlfferentlatlon of the cells (Table II). IL-4 alone did not 
induce dlfferentlatlon of M 1 cells, but It enhanced VD3- 
Induced morphological dlfferentlation (Table II) and 
phagocytlc actlnty of the cells (data not shown) Fur- 
thermore, the growth mhlbltlon by VD3 was markedly 
enhanced by IL-4, which alone did not mhlblt the 
growth of M 1 cells (Table II) Treatment of Ml cells 
with IL-4 and VD3 were not toxic, more than 90% of 
the cells remaining vaable Thus IL-4 enhanced the 
VDXnduced dlfferentlatlon and VD3-induced growth 
mhlbltlon of Ml cells, whereas IL-4 mhlblted the mduc- 
tlon of dlfferentlatlon and suppresslon of growth of M 1 
cells induced by the other differentlatlon mducers ex- 
ammed 
4 DISCUSSION 
Although IL-4 ltsclf had no slgnrficant effect on the 
growth or dlfferentlatlon of Ml cells, it suppressed the 
mductlon of differentiation of Ml cells induced by Dex, 
D-factor/LIF, IL-6 and alkyl ether hpld EG-6, and par- 
tlally restored the dlfferentlatlon-associated mhlbltlon 
of cell growth IL-4 inhibited the mductlon of dlfferen- 
tiatlon by these Inducers despite their structural dlffe- 
lences, suggesting that it may have a dmzct effect on M 1 
cells rather than actmg on the dlfferentlatlon inducers 
and/or their specific receptors. 
The mechanisms of the mhlbltory etfect of IL-4 on 
the mductlon of differentiation of M 1 cells are still un- 
known. Te Velde ct al [19] reported that IL-4 InhIbIted 
secretion of IL-4 by human monocytes Miydura et al 
[20] repolted that, although the production of IL-G wds 
stimulated by D-factor/LIF and VD3, the amounts of 
IL-6 secreted Into the culture medium did not appear to 
be enough to Induce differentlatlon of M 1 cells dnd thdt 
1-dbcl II 
Effect of IL-4 on mduct~on 01 dlWcrcntl.ltlon of Ml cells by VD3 
Trcdtmcnl IL-4 No of cdl\ 
(15 U/ml) (x10” wklml) Mduophdgcb (%) 
None l89k 9 0 
+ I98 Al4 0 
VD3 (0 25 rlgklll) - 188 .i 5 0 
+ 124 ,I(, 40 iOB 
VD3 (0 5 @ml) - IG4 AlO 53i26 
c 74 ill 17Gz.+30 
VD3 (I Ilg/ll~l) 104 il I 163?55 
c 34 c 4 30522 I 
--- 
MI clone S-2 cells (1x10” cclltiml) wcrc rulturcd with VD3 m 111~ 
prcscntc or iIbWIlCC d If_.-4 for 4 tklys vdiucs dtc ITlCdllS *SD (rr=l) 
the antl-IL-6 antlbody did not suppress the dlfferentla- 
tlon of Ml cells Induced by D-factor/LIF or VD3. 
Therefore, IL-6 does not appear to mediate the D- 
factor/LIF- or VDS-mduccd dlfferentratton of Ml cells. 
Marked dlfferentratlon of Ml clone S-2 cells was m- 
duced by Dex (Table I) but not by IL-6 [21]. These 
results suggest hat IL-6 does not mediate Dex-Induced 
dIfferentnatIon of Ml cells. In contrast, we found that 
IL-4 enhanced VD3-induced dlfferentlation of M 1 cells 
From these fndmgs, It 1s unlikely &hat he mhlbltlon of 
mductlon of dlfferentlatlon of Ml cells by IL-4 1s due 
to suppression of IL-6 production m Inducer-treated 
Ml cells. 
There are reports [ l&16,22,23] that some protemous 
substances mhlblt the mductlon of dlfferentlatlon of M 1 
cells I-factor [22] purified from condttloned medium of 
variant M 1 clone cells, tr ansformmg growth factor-/31 
(TGF-PI) [15,23] and Interferon-y (IFN-y) mhlblted the 
dlfferentlatlon of Ml cells Induced by Dex, VD3, D- 
factor/LIF, or IL-6 These mhlbltory effects on dlfferen- 
tlatlon of WI 1 cells were not assocrated with eesumptlon 
of cell growth Furthermore, the dlfferentlatlon of Ml 
cells was not mhlblted by other cytokines such as IL-l, 
IL-Z IL-3. IL-$ G-CSF, M-CSF and GM-CSF (data 
not shown). When Ml cells were cultured with Dex m 
the presence of both IL-4 and TGF-PI, the mhlbrtory 
effect on the Dex-Induced phagocytlc acttvlty of Ml 
cells was more than cumulative (data not shown) These 
results mdlcate that IL-4 Is a unique cytokme that mhl- 
bits dlfferentlatlon of myelold leukemia cells and that 
its actions on growth and dlfferentlatlon of M 1 cells arc 
different from those of l-factor, TGF-PI and IFN-y 
The effect of IL-4 on the dlfferentldtion of Ml cells 
did not vary with the clone of Ml cells used IL-4 mhl- 
b&d Dex or D-factol/LlF-induced dlffcrcntration of all 
clones of Ml cells used, whereas IL-4 enhanced VD3- 
induced dlfferentiatlon of dll the clones of M 1 cells used 
(Tdbles I and 11, Fig 2 and unpubhshed data) These 
results suggest hat the effect of IL-4 on dlfferentiatlon 
of M 1 cells 15 dependent on the diffcrentlatlon Inducer, 
rather than the clone of Ml cells used. 
The present results suggest that there are nt least two 
dlstmct pathways of monocytlc dlfferentlatlon of Ml 
cells One pathway mvolves several Inducers other than 
VD3-mduced dlfferentlatlon dnd IS mhlbltcd by IL-4, 
and the other pathway mvolves VD3-Induced dlffelen- 
tlatlon and IS stunulatcd by IL-4 AlternatIvely, VD3 
may mducc monocytlc dlffcrentlatlon by d umquc path- 
way(s) Mclnnes and Renmck [24] reported that IL-4 
mduccd fusion of bone marrow cells and alveolar mo- 
nocytcs to form giant multmuclcatecl ccl15 which wcrc 
assoclatcd with granulomatous lcslons formed m te- 
sponsc to foreign bodies, vtruscs, and bactcri‘t VD3, 
but not other drffcrenttatlon mduccrb, also induced fu- 
slon of alvcolat monocytcs to form giant multmuclcated 
cells [25]. Tdn,tka et ‘11. [LG] rcpoltcd that scvcral com- 
mon protcms of alvcol,tr monocytes were Induced by 
I83 
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IL-4 and VI33 but not other macrophage activators. 
Therefore, VD3 and IL-4 may mduce rnonocytlc d~ffe- 
rantiation to a spmfic subtype(s) of macrophages 
In this study, we found that IL-4 modulates growths 
and differentiations of M 1 sells miuced by several com- 
pounds. IL-4 n-my act on a partmlar step(s) in the 
process of induction of differentlatlon of Ml cells. 
Therefore, IL-4 should be useful for stxlym~ the rnsch- 
armms of rnonocytlc dlfferentiatnon of myeloid leuke- 
mia cells. 
Acknowledgements This work was supported m part by a Grant-m- 
Ald foe Cancer Research from the Muustry of Education, Science and 
Culture ofJapan, and a grant from the Mm~stry of Health and Welfare 
for a Comprehenslve IO-Year Strategy for Cancer Control, Japan 
REFERENCES 
[I] Howard, M , Hdfiker, M , Johnson, B , Takatsu, K and Paul, 
W E (1982) J Exp Med 155.914-923 
[2] Paul, W E and Qhara, J (1987) Annu Rev Immunol 5.429- 
460 
[3] Peschel. C , Paul, W E , Ohara, J and Green, I (1987) Blood 70, 
254-263 
[4] Renmck, D , Yang, G , Muller-Slebueg, C , Smith, C , Aral, N , 
Takabe, Y and Gemmell, L (1987) Proc Nat1 Acad SC! USA 
84,6889-6893 
[5] Broxmcyer, H E , Lu, L , Cooper, S , Tushmskl, R , Mochlzukl, 
D , Rubm, B Y , Gdls, § and Wdhams, D E (1988) J Immunol 
141, 3852-3862 
[G] Sonoda, Y , Okuda, T , Yokota, S, Maekawa, T, Shlzuml, Y , 
Nahlgakl, H , Mlsawa. S , FUJII, H and Abe, T (1990) Blood 75, 
1615-1621 
[7] Jansen, J H , Wdlem, G H M , Flbbe, W E , Wlllemze, R and 
Klum-Nelemans, H C (1989) J Exp Med 170, 577-582 
[8] Peck, R and Bollag, W (1991) Eur J Cancer 27, 53-57 
[9] Ichlkawa, Y (1969) J Cell Physlol 74, 223-234 
[IO] Honma, Y , Kasukabe, T , Okabe. J dnd Hozum~, M (1977) 
Gann 68,24l-246 
1111 
WI 
P31 
[I41 
WI 
iI61 
[I71 
[181 
v91 
PO1 
WI 
TomIda. M , Yamamoto-Yamaguchl, Y and Hozuml, M (1984) 
J Blol Chem 259, 10978-10982 
Myaura, C , Onozakl, K , Aklyama, Y , Tamyama, T , I-hraao, 
T , Klshlmoto, T and Suda, T (1988) FEBS Lett. 234, 17-21 
Abe, E , Mlyaura, C , Sakagaml, H , Takeda, K , Konno, K , 
Yamazakl, T , Yoshlkl, S and Suds, T (1981) Proc Nat1 Asad 
SCI USA 78,4990-4994 
Lowe, D G, Nuncs, W, Bombaea, M , McCabe, S, Ranges, 
G E , Henzel, W , TomIda, M , Yamamoto-Yamaguclu, Y , Ho- 
zuml, M and Goeddel, D V (1989) DNA 8, 351-359 
Okabe-Kado, 9, Honma, Y , Hayashl, M and Hozuml, M 
(1989) Jpn J Cancer Res 80, 228-232 
Yamamoto-Ydmaguchl, Y , TomId& M and Hozunu, M (1989) 
Leukemia Res 13, 253-257 
Kasukabe, T , Honma, Y , Hozuml, M , Suds, T and N~shu, Y , 
Cancer Res 47,567-572 
Kasukabe, T , Honma, Y , Hozuml, M and Nomura, H (1990) 
Jpn J Cancer Res 81.807-812 
Te Velde, A , HulJbens, R J F , HeiJe, K , De Vr~es, J E and 
Flgdor, C G (1990) Blood 76, 1392-1397 
Mlyaura, C , He Jm, C , Yamaguchl, Y , Tomlda. M , Hozuml, 
M , Matsuda, T , Hlrano, T , Klshlmoto, T and Suda, T (1989) 
Blochem Blophys Res Commun 158, 660-666 
Kasukabe, T , Okabe-Kado, J , Honma, Y , Hozuml, M , Mat- 
quda, T and Hleano, T , Leukemia Res , m press 
[22] Okabe-Kado, J , Kasukabe, T, Honma. Y , Hayashl, M and 
Hozuml, M (1988) J BIOI Chem 263, 1099410999 
1231 Lotem, J and Sachs, L (1990) Blood 76, 1315-1322 
[24] McInnes, A and Renmck, D M (1988) J Exp Med 167, 598- 
611 
[25] Abe. E , Myaura, C , Tanaka, I-1, Shnna, Y , Kurlbayashl, T , 
Suds, S , N~shu, Y , DcLuca, H F and Suds, T (1983) Proc 
Nat1 Acad SCI USA 80, 5583-5587 
[26] Tanaka, H , Shmkl, T, Hayashr, T, He Jm, C , Mlyaura, C., 
Abe, E and Suds, T (1989) Exp Cell Res 180. 72-83 
184 
